![Marc Berman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc Berman
Profile
Marc Berman worked as an Operations Director at Cylex, Inc..
Mr. Berman attended the University of Maryland where he earned an undergraduate degree.
Former positions of Marc Berman
Companies | Position | End |
---|---|---|
Cylex, Inc.
![]() Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Chief Operating Officer | 17/11/2013 |
Training of Marc Berman
University of Maryland | Undergraduate Degree |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
Cylex, Inc.
![]() Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Health Technology |
- Stock Market
- Insiders
- Marc Berman